BRIEF-Novo Nordisk Fiasp Approved In Europe

by Reuters
Thursday, 22 August 2019 06:13 GMT

Aug 22 (Reuters) - Novo Nordisk A/S:

* FIASP® APPROVED IN EUROPE FOR MANAGEMENT OF DIABETES IN ADOLESCENTS AND CHILDREN AGED ONE YEAR AND ABOVE

* EUROPEAN COMMISSION HAS GRANTED AN EXTENSION OF THE INDICATION FOR FIASP® (FAST-ACTING INSULIN ASPART), APPROVING IT FOR THE TREATMENT OF DIABETES IN ADOLESCENTS AND CHILDREN (AGED ONE YEAR AND ABOVE)

* THIS COMPLEMENTS THE PREVIOUS INDICATION, WHICH COVERED ADULTS ONLY Source text: https://bit.ly/2KP1yM4 Further company coverage: (Gdynia Newsroom)

Our Standards: The Thomson Reuters Trust Principles.